{"nct_id":"NCT02864251","title":"A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy","status":"COMPLETED","status_verified_date":"2023-09","start_date":"2017-03-17","start_date_type":"ACTUAL","primary_completion_date":"2022-01-20","primary_completion_date_type":"ACTUAL","completion_date":"2022-10-17","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}